Literature DB >> 14612149

Probing dopamine transporter structure and function by Zn2+-site engineering.

Claus Juul Loland1, Kristine Norgaard-Nielsen, Ulrik Gether.   

Abstract

The biogenic amine transporters belong to the class of Na+/Cl--coupled solute carriers and include the transporters for dopamine (DAT), norepinephrine (NET), and serotonin (SERT). These transporters are the primary targets for the action of many psychoactive compounds including the most commonly used antidepressants as well as widely abused drugs such as cocaine and amphetamines. In spite of their pharmacological importance, still little is known about their higher structural organization and the molecular mechanisms underlying the substrate translocation process. In this review, it will be described how we have used Zn2+-binding sites as a tool to probe the structure and function of Na+/Cl--coupled biogenic amine transporters with specific focus on the human DAT (hDAT). The work has not only led to the definition of the first structural constrains in the tertiary structure of this class of transporters, but also allowed inferences about conformational changes accompanying substrate translocation and residues critical for regulating the equilibrium between different functional states in the transport cycle.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14612149     DOI: 10.1016/j.ejphar.2003.08.068

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  15 in total

1.  Interaction of tyrosine 151 in norepinephrine transporter with the 2β group of cocaine analog RTI-113.

Authors:  Erik R Hill; Xiaoqin Huang; Chang-Guo Zhan; F Ivy Carroll; Howard H Gu
Journal:  Neuropharmacology       Date:  2011-03-21       Impact factor: 5.250

2.  Computational modeling of human dopamine transporter structures, mechanism and its interaction with HIV-1 transactivator of transcription.

Authors:  Yaxia Yuan; Xiaoqin Huang; Jun Zhu; Chang-Guo Zhan
Journal:  Future Med Chem       Date:  2016-10-14       Impact factor: 3.808

3.  Engineered zinc-binding sites confirm proximity and orientation of transmembrane helices I and III in the human serotonin transporter.

Authors:  Kellie J White; Philip D Kiser; David E Nichols; Eric L Barker
Journal:  Protein Sci       Date:  2006-10       Impact factor: 6.725

Review 4.  Role of zinc in the pathogenesis of attention-deficit hyperactivity disorder: implications for research and treatment.

Authors:  Peter Lepping; Markus Huber
Journal:  CNS Drugs       Date:  2010-09       Impact factor: 5.749

5.  Mechanism for cocaine blocking the transport of dopamine: insights from molecular modeling and dynamics simulations.

Authors:  Xiaoqin Huang; Howard H Gu; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2009-11-12       Impact factor: 2.991

6.  How dopamine transporter interacts with dopamine: insights from molecular modeling and simulation.

Authors:  Xiaoqin Huang; Chang-Guo Zhan
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

Review 7.  Phosphorylation of the Amino Terminus of the Dopamine Transporter: Regulatory Mechanisms and Implications for Amphetamine Action.

Authors:  Caline S Karam; Jonathan A Javitch
Journal:  Adv Pharmacol       Date:  2017-10-25

Review 8.  The role of human dopamine transporter in NeuroAIDS.

Authors:  Jun Zhu; Subramaniam Ananthan; Chang-Guo Zhan
Journal:  Pharmacol Ther       Date:  2017-10-05       Impact factor: 12.310

9.  Mutation of tyrosine 470 of human dopamine transporter is critical for HIV-1 Tat-induced inhibition of dopamine transport and transporter conformational transitions.

Authors:  Narasimha M Midde; Xiaoqin Huang; Adrian M Gomez; Rosemarie M Booze; Chang-Guo Zhan; Jun Zhu
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-05       Impact factor: 4.147

10.  Role of N-glycosylation in renal betaine transport.

Authors:  Eva S Schweikhard; Birgitta C Burckhardt; Friedericke Joos; Cristina Fenollar-Ferrer; Lucy R Forrest; Stephen A Kempson; Christine Ziegler
Journal:  Biochem J       Date:  2015-06-11       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.